Home › NDC Lookup › Ingredients › Camphor Menthol Methyl Salicylate › 65923-0564-20
Coralite Pain Relief Camphor, Menthol, Methyl Salicylate 1.2 g/100g; 5.7 g/100g; 6.3 g/100g Patch, 20 patches — NDC 65923-0564-20 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Coralite Pain Relief Camphor, Menthol, Methyl Salicylate 1.2 g/100g; 5.7 g/100g; 6.3 g/100g Patch, 20 patches — NDC 65923-564-20 (Billing 65923-0564-20)

by United Exchange Corp. · 20 PATCH in 1 PACKAGE / 1 g in 1 PATCH

This is a package of 20 patches of Coralite Pain Relief Camphor, Menthol, Methyl Salicylate 1.2 g/100g; 5.7 g/100g; 6.3 g/100g Patch from United Exchange Corp., marketed since Apr 2016 and currently FDA-listed. It is this product's only package size.

NDC 65923-0564-20
🏷️ FDA NDC (as labeled) 65923-564-20 billing pads the product segment with a zero
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 65923-564-20 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
65923 labeler · 564 product · 20 package
Package marketed since
Apr 12, 2018
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC)
0780707901564
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 65923-564-20
Product NDC 65923-564
11-digit billing NDC 65923056420
RxCUI 853260
UNII 5TJD82A1ET, L7T10EIP3A, LAV5U5022Y
UPC 0780707901564
Application # M017
SPL Set ID 69aec845-3d4c-d226-e053-2991aa0afd12
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2016-04-12
Route TOPICAL
Dosage form PATCH
Substance CAMPHOR (SYNTHETIC); MENTHOL; METHYL SALICYLATE
Quick answers
  • RxCUI (RxNorm): 853260
Why two NDCs? The FDA registers this code as 65923-564-20 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 65923-0564-20. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Coralite Pain Relief is a topical patch containing three counterirritant ingredients: camphor, menthol, and methyl salicylate. These ingredients are commonly used in over-the-counter pain relief products to create a warming or cooling sensation on the skin. This is an OTC monograph drug, meaning it is marketed under FDA's established rules for this category of topical pain relievers rather than as an individually reviewed application.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
65923-0564-20 You're viewing this Main listing 20 PATCH in 1 PACKAGE / 1 g in 1 PATCH 2018-04-12 — Active

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Pain Relieving Patches 1.2 g/100g; 5.7 g/100g; 6.3 g/100g 00363-9903-40 Walgreen 40 pouches — — FDA listed —
Profoot Pain Relief Patches 29784-0600-01 Rooftop 4 patches — — FDA listed —
Profoot Pain Relief Patches 29784-0601-01 Profoot, 1 patch — — FDA listed —
Profoot Plantar Relief Strips 12 mg/g; 57 mg/g; 63 mg/g 29784-0602-01 Rooftop 4 patches — — FDA listed —
TopCare Health Pain Relief .012 mg/g; .057 mg/g; .063 mg/g 36800-0670-40 Topco 40 patches — — FDA listed —
Coralite Muscle and Joint Pain Relief 12 mg/g; 57 mg/g; 63 mg/g 65923-0148-02 United 1 patch — — FDA listed —
Coralite Pain Relief 1.2 g/100g; 5.7 g/100g; 6.3 g/100gthis 65923-0564-20 United 20 patches — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2016
On the market since
Apr 2016
📍
2026
Currently FDA-listed
10 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII T1FAD4SS2M
    Aluminum silicate is a mineral compound used as a thickener, absorbent, and anti-caking agent in medicines. It helps give liquid or powder formulations the right texture and prevents clumping.
  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII SD112V492J
    Glyceryl rosinate is a sticky substance made by combining rosin (a natural resin from pine trees) with glycerin. It's used in medicines as a binder to help hold solid ingredients together and improve texture and spreadability in certain formulations.
  • UNII 7EV65EAW6H
    Lanolin is a waxy substance derived from sheep's wool. It's used in medicines as an emollient and skin-conditioning agent to soften formulations and improve spreadability in topical products like creams and ointments.
  • UNII 2LQ0UUW8IN
    A natural rubber material derived from the rubber tree. It's used as a coating or component in capsule shells and drug delivery devices to provide structure, flexibility, and controlled release of the medication.
  • UNII I9O0E3H2ZE
    Paraffin is a waxy, petroleum-derived substance used as a coating, lubricant, and hardening agent in tablets and capsules. It helps protect the medicine from moisture and gives pills a smooth finish.
  • UNII Y132ZOQ9H7
    A synthetic rubber-like polymer used as a binder and thickening agent in medicines. It helps hold tablet ingredients together and can improve the texture and consistency of formulations.
  • UNII 7X53O5S2ZY
    Polyisobutylene is a synthetic rubber-like polymer used as a glidant and lubricant in tablet and capsule formulations. It reduces friction between particles and equipment during manufacturing and processing.
  • UNII K7S96QM8DV
    A synthetic rubber-like plastic made from linked chains of styrene and isoprene. It's used in medicines as a binder to hold ingredients together and as a film-former to create protective coatings on tablets or capsules.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII SOI2LOH54Z
    Zinc oxide is a white mineral powder used in medicines as a protective barrier agent and color additive. It helps shield skin in topical products and may also serve as a filler or opacifying ingredient.

11 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients aluminum silicate, butylated hydroxytoluene, glyceryl rosinate, lanolin, natural rubber, paraffin, polyisobutylene (800000 mw), polyisobutylene (85000 mw), styrene-isoprene-styrene block copolymer, titanium dioxide, zinc oxide

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerUnited Exchange Corp.
FDA applicationM017 (OTC MONOGRAPH DRUG)
Labeler code65923
First marketedApr 2016
Product typeHuman Otc Drug
Portfolio22 products on file

More NDCs from United Exchange Corp. labeler code 65923

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 49 words ▾

Directions adults and children 12 years of age and over: clean and dry affected area remove patch from film apply to affected area not more than 3 to 4 times daily do not wear patch for more than 4 hours children under 12 years of age: consult a doctor

⏱️ Dosage and Administration 12 words ▾

Distributed by: United Exchange Corp. Cypress, CA 90630 USA Made in China

⚠️ Warnings 21 words ▾

Warnings For external use only Allergy alert: If prone to allergic reaction from aspirin or salicylates, consult a doctor before use.

📦 Storage and Handling 12 words ▾

Other information avoid storing product in direct sunlight protect from excessive moisture

🧪 Active Ingredient 13 words ▾

Active ingredients Purpose Camphor 1.2%........................................Topical Analgesic Menthol 5.7%..........................................Topical Analgesic Methyl Salicylate 6.3%............................Topical Analgesic

🧪 Inactive Ingredients 25 words ▾

Inactive ingredients aluminum silicate, butylated hydroxytoluene, glyceryl rosinate, lanolin, natural rubber, paraffin, polyisobutylene (800000 mw), polyisobutylene (85000 mw), styrene-isoprene-styrene block copolymer, titanium dioxide, zinc oxide

🎯 Purpose 21 words ▾

Uses For temporary relief of minor aches & pains of muscles & joints associated with: arthritis simple backache strains bruises sprains

📄 Do Not Use 33 words ▾

Do not use on wounds or damaged skin with a heating pad if you are allergic to any ingredients of this product on a child under 12 years of age with arthritis-like conditions

📄 Ask a Doctor Before Use If 13 words ▾

Ask a doctor before use if you have redness over the affected area.

📄 When Using This Product 43 words ▾

When using this product do not use other than directed avoid contact with the eyes, mucous membranes or rashes do not bandage tightly discontinue use at least 1 hour before a bath or shower do not use immediately after a bath or shower

📄 Stop Use and Ask a Doctor If 35 words ▾

Stop use and ask a doctor if redness is present or irritation or rash develops condition worsens or symptoms persist for more than 7 days symptoms clear up and occur again within a few days

🤰 If Pregnant or Breast-Feeding 10 words ▾

If pregnant or breast-feeding, ask a health professional before use.

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or conduct a Poision Control Center right away

📄 Package Label / Principal Display Panel 1 words ▾

90156

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Coralite Pain Relief (this brand).

Top reported reactions

Application Site Burn2
Application Site Erythema1
Application Site Pain1
Application Site Pruritus1
Chemical Burn1
Hyperhidrosis1
Scar1

Reporter sex

4 reports
Male · 50%
Female · 50%
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by United Exchange Corp.. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
United Exchange Corp. is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 65923-0532-18 · United 65923-0570-15 · United →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.